At close: December 13 at 4:00:01 PM EST
After hours: December 13 at 5:00:19 PM EST
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-84,307.00
-81,067.00
-31,866.00
-66,907.00
-42,221.00
Investing Cash Flow
-93,523.00
105,946.00
-45,882.00
-76,426.00
-1,050.00
Financing Cash Flow
137,869.00
53,007.00
46,409.00
1,284.00
108,108.00
End Cash Position
150,585.00
192,011.00
114,125.00
145,464.00
287,513.00
Capital Expenditure
-390.00
-1,616.00
-3,962.00
-1,200.00
-1,050.00
Issuance of Capital Stock
136,177.00
52,081.00
45,344.00
--
105,398.00
Free Cash Flow
-84,697.00
-82,683.00
-35,828.00
-68,107.00
-43,271.00
12/31/2020 - 6/19/2019
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
AKRO Akero Therapeutics, Inc.
28.89
-0.48%
CRNX Crinetics Pharmaceuticals, Inc.
53.66
-3.52%
NRIX Nurix Therapeutics, Inc.
20.27
-1.41%
ALEC Alector, Inc.
1.9700
-3.43%
ACLX Arcellx, Inc.
83.80
+0.46%
ANAB AnaptysBio, Inc.
15.59
+3.79%
SLRN Acelyrin, Inc.
3.2300
-8.76%
PTGX Protagonist Therapeutics, Inc.
41.08
+1.73%
BCYC Bicycle Therapeutics plc
13.81
-31.33%
OKUR OnKure Therapeutics, Inc.
9.86
-8.96%